Episode 219: ASCO GU 2023: Neeraj Agarwal, MD...

Mary Ellen Taplin joins us on the heels of her ASCO 2026 Plenary presentation with this exciting phase 3 data certain to generate discussion about the landscape of high risk prostate cancer. 

Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets. 

JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.

Rela ...

Combined Otolaryngology Spring Meetings Chair Patrick Ha, MD, and Co-Chairs Nicole C. Schmitt, MD, and Sidharth V. Puram, MD, PhD, share late-breaking research from the annual Combined Otolaryngology Spring Meetings in an interview hosted by JAMA Otolaryngology Web Editor Paul C. ...  Show more

Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke an ...  Show more

Dr. Refky Nicola discusses the Society of Radiologists in Ultrasound Consensus Conference recommendations on management of incidentally detected gallbladder polyps with Dr. Paul Sidhu. Management of Incidentally Detected Gallbladder Polyps: Society of Radiologists in Ultrasound C ...  Show more